Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medeca Pharma is a Swedish pharmaceutical company focused on the commercialization of allergy treatments and emergency medicine. The company is primarily recognized for marketing Jext, a pre-filled adrenaline auto-injector used for the emergency treatment of severe acute allergic reactions, known as anaphylaxis. Based in Uppsala, Sweden, Medeca has built a significant market presence in Northern Europe and other international territories. In 2011, the company was acquired by ALK-Abelló, a global leader in allergy immunotherapy. This acquisition allowed ALK to integrate Medeca's emergency treatment portfolio into its broader range of allergy products. Today, Medeca operates as part of the ALK group, continuing to provide essential life-saving medication to patients with severe allergies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medeca Pharma.